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Friedreich ataxia (FRDA) patients are homozygous for expanded GAA triplet-repeat alleles in the FXN gene. Primary neurodegeneration
involving the dorsal root ganglia (DRG) results in progressive ataxia. While it is known that DRG are inherently sensitive to frataxin deficiency,
recent observations also indicate that they show age-dependent, further expansion of the GAA triplet-repeat mutation. Whether somatic
instability is progressive has not been systematically investigated in FRDA patients. “Small-pool” PCR analysis of ∼2300 individual molecules
from tissues of an 18-week fetus homozygous for expanded alleles revealed very low levels of instability compared with adult-derived tissues
(4.2% versus 30.6%, pb0.0001). Mutation load in blood samples from multiple patients and carriers increased significantly with age, ranging
from 7.5% at 18-weeks gestation to 78.7% at 49 years of age (R=0.91; p=0.0001). Therefore, somatic instability in FRDA occurs mostly after
early embryonic development and progresses throughout life, lending further support to the role of postnatal somatic instability in disease
pathogenesis.
© 2007 Elsevier Inc. All rights reserved.Keywords: Friedreich ataxia; GAA triplet repeat; Instability; Progressive; Embryonic development; Somatic instabilityFriedreich ataxia (FRDA) is characterized by slowly prog-
ressive sensory ataxia with onset usually before the age of
25 years, typically associated with absent tendon reflexes, loss
of position and vibration senses, dysarthria, and extensor plantar
responses [1,2]. These neurological manifestations result from
primary degeneration of the dorsal root ganglia (DRG),
associated with axonal degeneration in the posterior columns,
spinocerebellar tracts, and corticospinal tracts of the spinal cord
and large myelinated fibers in the peripheral nerves [3].
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doi:10.1016/j.ygeno.2007.04.001loss of ambulation is 25 years, and patients often die in their
fourth or fifth decade.
FRDA is inherited as an autosomal recessive trait and the
vast majority of patients are homozygous for expanded GAA
triplet-repeat (GAA-TR) sequences (E alleles) in intron 1 of the
FXN gene [4]. E alleles interfere with FXN gene transcription in
a length-dependent manner [5,6] and result in proportional
deficiency of frataxin [7]. Most E alleles contain 600–1200
triplets; however, the spectrum of disease-causing alleles ranges
from 66 to 1700 triplets. Disease severity and rate of
progression correlate with the length of E alleles [8–12], and
carriers of shorter alleles (fewer than 500 triplets) commonly
show slower than average disease progression.
DRG neurons are especially sensitive to frataxin deficiency,
as was demonstrated by their selective loss in neuronal-specific,
conditional, frataxin-knockout mice [13]. Upon analysis of
Fig. 1. SP-PCR showing significantly low levels of somatic instability in fetal
tissues. (A and B) Southern blots showing limited somatic variability in
representative tissues of (A) an 18-week fetus and (B) a 24-year-old adult
patient, each of whom are homozygous for E alleles. Each lane contains small
pools of 12–20 individual FXN molecules. Arrowheads indicate the position of
the constitutional allele determined by conventional PCR. Asterisks indicate rare
instances of large expansions/contractions despite the overall low level of
somatic instability. DNA size markers are shown as dashes along the right
margin, which indicate the relative positions of 1 (182 triplets), 2 (515 triplets), 3
(849 triplets), and 4 kb (1182 triplets). (C) Cumulative average mutation load of
all fetal versus adult (patient A-1) tissues analyzed showing a highly significant,
7.3-fold lower level of somatic instability in fetal tissues compared with adult
tissues. Error bars depict ±2 SEM.
2 I. De Biase et al. / Genomics 90 (2007) 1–5nervous system tissue from multiple autopsies of FRDA
patients we recently found that there was a progressive
accumulation of large expansions in the DRG [14]. This
phenomenon was not seen in other tissues and may serve as a
further modulator of the progressive DRG-specific pathology
seen in FRDA patients. Furthermore, in patients who are
compound heterozygous for a conventional E allele and a
borderline GAA-TR allele (44–66 triplets), somatic instability
of the borderline allele was required for the development of the
FRDA phenotype [15].
All of the above observations suggest that somatic instability
of E alleles in FRDA is likely to be progressive. However, this
has not been systematically investigated in patient-derived
tissues. Given that DNA replication is able to induce instability
of GAA-TR sequences in simple model systems [16,17], one
would predict that the burst of cellular proliferation occurring in
early embryonic development would be associated with
enhanced somatic instability. Here we show that somatic
instability of E alleles is progressive; it occurs mostly after
early embryonic development and continues throughout life.
These observations have important implications for the
mechanism of somatic instability in FRDA and lend further
support to the role of progressive somatic instability in disease
pathogenesis.
Results
Somatic instability in FRDA occurs mainly after early
embryonic development
E alleles are commonly detected by conventional PCR or
genomic Southern blot analyses, which typically use 0.06–
6 μg genomic DNA, thus simultaneously analyzing 104–106
cells. These assays, commonly used for molecular diagnosis
of patients, estimate the repeat length of only the “constitu-
tional” or “most common” allele (E allele). However, using
“small-pool” PCR (SP-PCR), a sensitive assay that involves
the use of very low levels of genomic DNA (typically 6–
600 pg), it is possible to detect GAA triplet repeats in
individual FXN molecules (genes) [15,18]. SP-PCR analysis
of DNA from tissues of an 18-week fetus, homozygous for
E alleles, revealed a remarkably low level of instability in all
tissues tested (Fig. 1A; Table 1). Conventional PCR showed
homozygous E alleles of the same size (620/620 triplets in
blood), which therefore allowed accurate determination of
the magnitude of allelic size variation. Analysis of 2320
individual FXN molecules from multiple tissues revealed a
cumulative mutation load of 4.2% (Table 1). Compared to a
24-year-old FRDA patient homozygous for two E alleles of
the same size (943/943 by conventional PCR analysis), fetal
tissues had 7.3-fold less instability than the corresponding
adult-derived tissues (4.2% versus 30.6%, pb0.0001; Figs.
1B and 1C; Table 1). The overall mutation load is skewed in
favor of contractions (3- to 4-fold more contractions) in both
adult and fetal tissues (Table 1). Analysis of an additional
572 molecules from a primary fibroblast cell line derived
from the fetus also revealed similarly low levels of in-stability (2.1%). Blood and cerebellum showed the highest
mutation load. Interestingly, these tissues also revealed the
highest frequency of large mutations (±20% of the progenitor
allele length), which amounted to 15 and 31% of all muta-
tions in blood and cerebellum, respectively (examples are
indicated by asterisks in Fig. 1A). Together, these data
indicate that the relatively high level of somatic instability
observed in adult-derived tissues develops after early em-
bryonic development.
It is known that non-GAA interruptions within an E allele
can stabilize the sequence in somatic cells in vivo [17]. To rule
out the possibility that similar intra-allelic interruptions may be
the reason for the stability seen in fetal tissues, we analyzed
blood samples from the parents of the fetus to test if the
inherited E alleles were capable of developing somatic
instability. In contrast to the fetal sample, SP-PCR analysis of
Table 1
Tissue Fetus Adult a
Molecules Mutation load Contractions Expansions Molecules Mutation load Contractions Expansions p value b
Blood 548 41 (7.5%) 29 (5.2%) 12 (2.1%) 1347 567 (42.1%) 524 (38.9%) 43 (3.2%) b0.0001
Cerebrum 873 14 (1.6%) 13 (1.5%) 1 (0.1%) 1249 274 (21.9%) 215 (17.2%) 59 (4.7%) b0.0001
Cerebellum 483 34 (7%) 25 (5.2%) 9 (1.9%) 1008 273 (27.1%) 212 (21%) 61 (6.1%) b0.0001
Spinal cord 156 1 (0.6%) 1 (0.6%) 0 (0%) 269 99 (36.8%) 80 (29.7%) 19 (7.1%) b0.0001
Heart 156 6 (3.8%) 4 (2.6%) 2 (1.2%) 711 193 (27.1%) 113 (15.8%) 80 (11.3%) b0.0001
Pancreas 104 1 (1%) 1 (1%) 0 (0%) 619 187 (30.2%) 114 (18.4%) 73 (11.8%) b0.0001
Total 2320 97 (4.2%) 73 (3.1%) 24 (1%) 5203 1593 (30.6%) 1258 (24.2%) 335 (6.4%) b0.0001
a Autopsy of a 24_year_old FRDA patient.
b Comparison of mutation load.
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parents showed significantly higher mutation loads [61.5%
(maternal), 49.8% (paternal) versus 7.5% (fetal); pb0.0001 in
both cases; Fig. 2B. This difference is unlikely to be due to the
length of the E alleles since the maternal E allele (680 triplets)
was similar in size to the fetal E alleles (620 triplets). This
indicates that the fetal E alleles are indeed capable of
developing somatic instability, but are nevertheless stable due
to the younger age.Fig. 2. SP-PCR showing instability of alleles inherited by the fetus in both
heterozygous parents. (A) Representative SP-PCR results showing high levels
of somatic instability of the E alleles in blood samples from the heterozygous
carrier parents of the fetus (the arrowhead indicates the position of the single E
allele in each parental blood sample as determined by conventional PCR;
normal alleles are not shown). This indicates that both E alleles that were
transmitted to the homozygous offspring are inherently capable of somatic
instability. Each lane contains small pools of 17–20 individual FXN molecules.
DNA size markers are shown as dashes along the right margin, which indicate
the relative positions of 1 (182 triplets), 2 (515 triplets), 3 (849 triplets), and
4 kb (1182 triplets). (B) Bar graph of mutation load in the blood of fetus versus
both parents (combined) showing a highly significant, sevenfold lower level of
somatic instability in fetal tissues compared with adult tissues. The error bar
depicts ±2 SEM.Somatic instability in FRDA progresses throughout life
SP-PCR analysis of 6288 individual FXN molecules derived
from a panel of blood samples from FRDA patients and
heterozygous carriers with ages ranging from 2 to 49 years
(Supplementary Table 1) showed mutation loads ranging from
17 to 78.7%, and it correlated significantly with the age of the
donor (R=0.88; p=0.0007). Including the blood sample from
the fetus, the mutation loads ranged from 7.5 to 78.7% and
showed a highly significant correlation with age (R=0.91;
p=0.0001; total 6835 individual FXN molecules; Fig. 3), with
donor age accounting for 83% of the variability. The donors
were homozygous/heterozygous for constitutional E alleles of
various sizes as determined by conventional PCR (346–1000
triplets; Supplementary Table 1); however, no statistically
significant allele length effect was observed (p=0.18 and
p=0.39 for the longer and shorter E alleles, respectively). These
data indicate that somatic instability in vivo is progressive and
increases throughout life.
Discussion
The age-dependent increase in mutation load and the
remarkably low level of instability through early embryonic
development indicate that DNA replication is unlikely to be the
only mechanism for somatic instability in FRDA patients. The
age-dependent increase in mutation load in peripheral blood
cells, despite their limited life span in the circulatory system,Fig. 3. Age-dependent increase in somatic instability in FRDA patients and
carriers. Mutation load (y axis) is plotted against age (in years; x axis) for blood
samples derived from 10 individuals. Their ages include 18-weeks gestation
(plotted as 0 years) and 2, 9, 16, 17, 24, 29, 36, 43, and 49 years. Error bars
indicate 95% confidence intervals.
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hematopoietic progenitors and not through the many cell
divisions occurring from the progenitor cell stage through end
cells in the peripheral circulation.
Our data contrast with the frequent observation of DNA
instability in simple replication model systems established in
Escherichia coli [17] and Saccharomyces cerevisiae [16].
However, they are consistent with the observation of progres-
sive somatic instability of expanded (CAG·CTG)n repeats in
tissues from patients with Huntington disease [19] and
myotonic dystrophy [20–22] and in transgenic mouse models
[23–25]. It is noteworthy that this commonality transcends
obvious differences in the physical properties of the two repeat
sequences and their genomic locations. Despite this general
similarity, instability of the expanded GAA-TR sequence
involves mainly contractions [18], as opposed to mainly
expansions of the (CAG·CTG)n sequence. Furthermore,
somatic instability of the (CAG·CTG)n sequence is thought
to progress in small incremental steps [20–22], but our data
from fetal tissues show that somatic instability in FRDA may
include large expansions and contractions. Indeed, given the
overall low level of mutation in fetal tissues, the rather high
prevalence of large mutations in blood and cerebellum indicate
that the latter are single mutation events and are not due to
multiple incremental mutations. It remains to be seen if
mammalian mismatch repair proteins, so critical for the
development of somatic instability of (CAG·CTG)n repeats
[26–29], also mediate somatic instability of the GAA-TR
sequence.
A potential weakness of our study is that, despite consider-
able effort, we were able to ascertain tissues from only one fetus
homozygous for expanded GAA-TR alleles. However, the
demonstration of instability in both parental alleles supports the
case that the fetal alleles are inherently capable of somatic
instability. Moreover, the lower instability of the 2-year-old
individual (mutation load 17.5%) and the statistically significant
trend of increasing somatic instability through middle age
(49 years) support our conclusion that somatic instability in
FRDA is mostly postnatal and progresses throughout life.
Another caveat of our study involves the use of multiple
individuals of varying ages instead of studying a selected group
of patients over time. However, the highly significant statistical
correlation of mutation load with patient age, the lack of
correlation with allele length, the similarity of mutation load in
patients of similar ages (16 years versus 17 years, p=0.95, and
24 years versus 29 years, p=0.52), and our recent observation of
age-dependent increase in somatic instability in a transgenic
mouse model [30] all support the conclusion that somatic
instability of expanded GAA-TR sequences at the FXN locus is
age-dependent.
The age-dependent progression of somatic instability pro-
vides a conceptual framework for the connection between
disease pathogenesis and somatic instability in FRDA. The
observation that mutation load in blood increases throughout life
and the dramatic difference between multiple fetal and adult
tissues suggest that it is likely a generalized phenomenon. This is
likely to be the basis of the development of late onset FRDA inpatients who carry one borderline allele (44–66 triplets) and one
conventional E allele (66–1700 triplets). Borderline alleles are
thought to be too short to impede FXN gene transcription, but
accumulation of expansions via somatic instability is thought
to underlie the development of the FRDA phenotype [15].
Given our present results, we propose that progressive somatic
instability of borderline alleles results in late onset FRDA.
Moreover, the age-dependent accumulation of large expansions
in DRG of FRDA patients [14] is further supported by our
current observation of progressive somatic instability in human
tissues.
In summary, the expanded GAA triplet-repeat sequence
displays an age-dependent increase in mutation load in somatic
cells in vivo. Progressive somatic instability may contribute to
disease pathogenesis in Friedreich ataxia.
Materials and methods
Tissue samples
Samples from pediatric and adult FRDA patients and carriers were collected
using institutionally approved protocols at the University of Oklahoma Health
Sciences Center and the Instituto Nacional de Neurología y Neurocirugía.
Autopsy material from the 18-week fetus homozygous for expanded GAA
triplet-repeat sequences in the FXN gene was obtained from the Telethon Bank
of Fetal Biological Samples in the Facoltá di Medicina e Chirurgia, University of
Naples “Federico II,” Italy (Director: Professor Lucio Nitsch; funded by
Telethon Italia). Pediatric and adult tissues were processed and analyzed in the
Bidichandani lab in Oklahoma City (OK, USA). All fetal tissues were processed
and analyzed in the Cocozza lab in Naples (Italy).
Small-pool PCR analysis
This was performed as described previously [18,31]. Briefly, serial dilu-
tions of human genomic DNA (starting in the range of 6–600 pg) were
prepared in siliconized microfuge tubes. PCR was performed using primers
147F (5′-GAAGAAACTTTGGGATTGGTTGC-3′) and 602R (5′-AGGAC-
CATCATGGCCACACTT-3′). PCR products were detected by Southern
blotting using an end-labeled (TTC)9 oligonucleotide probe. The calculation
of the number of individual molecules per reaction was performed by Poisson
analysis as described previously [18,31]. For each genomic DNA sample,
multiple reactions were performed using small pools of 10–25 individual
molecules per reaction to detect mutations. Mutation load was calculated as
the proportion of amplified FXN molecules that differed by N5% in length
from the constitutional (most common) allele, as determined by conventional
PCR.
Statistical analysis
Proportions were compared using the χ2 test, and correlation of insta-
bility with age/allele length was calculated using Pearson’s coefficient of
correlation.
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